ITGAM and neoplasm: Moreover, combining E2 with anti-PD-L1 treatment synergistically reduced PD-L1 expression in tumor tissues, diminished the population of PD-L1-expressing tumor cells and TAMs (CD11b+F4/80+), and significantly inhibited MC38 tumor growth in male mice.